Page 124 - Technological Development News Today

Peruvian researchers seek to convert agro-industrial pomegranate waste into high-value raw material The Jorge Basadre Grohmann National University (UNJBG) and the Private University of Tacna (UPT), with the support of the National Fund for Scientific, Technological Development and Technological Innovation (Fondecyt), have been developing a project to convert the agroindustrial waste of pomegranates into high-value raw material. This fruit is characterized by its high concentration of antioxidan...

Vranje, Serbia, 19 March 2021 - “ I want to live in Finland and be a doctor or dentist. I think school is very important, not just for me, but for everyone”, twelve-year-old Roma tells us confidently. She speaks five languages, paints, has the best grades in school. She is sociable, open, has a sense of humour. But no child should experience the things this girl has in the last five years. She fled Iraq with her mother, father and two younger brothers. She lived in refugee and...

Angle PLC Announces Parsortix study uncovers targets in TNBC patients ACCESSWIRE Parsortix system harvests intact CTCs for whole genomic sequencing identifying multiple druggable targets Study demonstrates ctDNA and CTCs can both be analysed using the same blood sample GUILDFORD, UK / ACCESSWIRE / May 11, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that a leading cancer research institute, Fondazione IRCCS Istituto Nazionale dei Tumori,...

About ANGLE plc   www.angleplc.com   ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLEs proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLEs cell separation technology is called the Parsortix ® system, and it enables a liquid biopsy (a simple blood ...

Open access ‘excludes’ developing world scientists A model that charges researchers to publish their work in open access journals hurts many researchers in the global South. Copyright: National Institutes of Health, USA, public domain image. Speed read Salaries of researchers in developing world range from US$350 to about US$3,000 Waiver systems ‘too complex and bureaucratic’ Share this article: Republish We encourage you to republish this article online and in print, it’s free unde...

This week the first tenants moved into a 3D-printed home According to the developers, it is the first time in Europe that people have actually lived in a 3D-printed home. Built by Portugals Institute for Research and Technological Development for Construction, Energy, Environment and Sustainability, the 516-metre-long bridge is suspended 175 metres above the Paiva river. In the UK, interest in the renovation of prime minister Boris Johnsons flat at 11 Downing Street was the centre of attentio...

Beijing has recently implemented a number of preferential policies for domestic and foreign investors in the service industry and established a free trade zone.   As such, the capital is welcoming companies, partners and international institutions from all over the world to enjoy the benefits of its development.   "Beijings further opening-up of the service sector and the establishment of the FTZ have brought crucial opportunities that will drive the citys high-quality development," said Liu ...

 E-Mail IMAGE: Pathway of mutant p53 from liquid droplets to gel-like and solid-like (amyloid) states, in vitro and in cell. view more  Credit: Guilherme de Oliveira Cancer has been recently shown to be affected by protein clusters, particularly by the aggregation of mutant variants of the tumor suppressor protein p53, which are present in more than half of malignant tumors. However, how the aggregates are formed is not yet fully understood. The understanding of this process is expect...

Article Title: Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil Funding: MMS: This study was supported by CGLab/MoH (General Laboratories Coordination of Brazilian Ministry of Health), CVSLR/FIOCRUZ (Coordination of Health Surveillance and Reference Laboratories of Oswaldo Cruz Foundation), The National Council for Scientific and Technological Development (CNPq) COVID-19 MCTI 402457/2020-0, INOVA VPPCB-005-FIO-20-2-69, and Carlos...

Share this News Fernando Peirano, president of the National Agency for the Promotion of Research, Technological Development and Innovation (Agencia I+D+i). | PERFIL/CEDOC Argentina will be self-sufficient next year in vaccine production, according to Fernando Peirano, president of the National Agency for the Promotion of Research, Technological Development and Innovation (Agencia I+D+i). In an interview with the Noticias Argentinas news agency, Peirano refused to pin down his prediction to a ...